M
Measles, Mumps, Rubella & Varicella Vaccine (MMRV) [Priorix-Tetra]
Availability of ACE Drug Guidance
No
Biologics Drug Information Overview
No
Subsidy Information and Financing Scheme
Subsidised Vaccine List
Active ingredients: Vaccine Measles | Measles Vaccine | Vaccine Mumps | Mumps Vaccine | Vaccine Rubella | Rubella Vaccine | Vaccine Varicella | Varicella Vaccine | Measles, Mumps, Rubella & Varicella Vaccine (MMRV)
General information
Subsidy Information and Financing Scheme
[SVL] Measles, Mumps, Rubella & Varicella Vaccine (MMRV) (Priorix-Tetra) Injection, Measles Virus Vaccine (live-attenuated) minimum 103.0 CCID50/0.5 mL + Mumps Virus Vaccine (live-attenuated) minimum 104.4 CCID50/0.5 mL + Rubella Virus Vaccine (live-attenuated) minimum 103.0 CCID50/0.5 mL + Varicella-Zoster Virus Vaccine (live, attenuated) minimum 103.3 plaque-forming units/0.5 mL
National Childhood Immunisation Schedule (NCIS)
Drug Guidance for Subsidy
Not Applicable
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information. |
Subcutaneous / Intramuscular
* Clinical information is available for this product.